-       Report 
- October 2025
-  198 Pages 
- Global 
   From       €3154EUR$3,545USD£2,769GBP 
      €3505EUR$3,939USD£3,076GBP 
          -       Report 
- October 2025
-  178 Pages 
- Global 
   From       €5205EUR$5,850USD£4,569GBP 
          -       Report 
- January 2025
-  175 Pages 
- Global 
   From       €3995EUR$4,490USD£3,507GBP 
          -       Report 
- November 2024
-  110 Pages 
- Global 
   From       €5294EUR$5,950USD£4,647GBP 
            -       Report 
- October 2025
-  199 Pages 
- Global 
   From       €3154EUR$3,545USD£2,769GBP 
      €3505EUR$3,939USD£3,076GBP 
             -       Report 
- August 2025
-  196 Pages 
- Global 
   From       €3154EUR$3,545USD£2,769GBP 
      €3505EUR$3,939USD£3,076GBP 
          -       Report 
- October 2025
-  272 Pages 
- Global 
   From       €5205EUR$5,850USD£4,569GBP 
          -       Report 
- October 2025
-  178 Pages 
- Global 
   From       €5205EUR$5,850USD£4,569GBP 
          -       Report 
- October 2025
-  181 Pages 
- Global 
   From       €5205EUR$5,850USD£4,569GBP 
          -       Report 
- April 2025
-  200 Pages 
- Global 
   From       €3995EUR$4,490USD£3,507GBP 
          -       Report 
- February 2025
-  200 Pages 
- Global 
   From       €3995EUR$4,490USD£3,507GBP 
          -       Report 
- August 2022
-  202 Pages 
- Global 
   From       €4270EUR$4,799USD£3,748GBP 
          -       Report 
- July 2024
-  120 Pages 
- Global 
   From       €5294EUR$5,950USD£4,647GBP 
          -       Report 
- November 2023
-  178 Pages 
- Global 
   From       €4004EUR$4,500USD£3,514GBP 
          -       Report 
- October 2022
-  119 Pages 
- Global 
   From       €4004EUR$4,500USD£3,514GBP 
           
      Gene Cloning is a process used in genomics to create copies of genes or other DNA fragments. It is used to produce large amounts of a particular gene or gene product for research or therapeutic purposes. The gene cloning market is driven by the increasing demand for gene-based therapies, the growing prevalence of genetic diseases, and the increasing use of gene-based diagnostics. The market is also driven by the increasing investments in genomics research and the increasing demand for personalized    medicine.
The gene cloning market is segmented into products, services, applications, and end-users. The products segment includes reagents, kits, enzymes, and other consumables. The services segment includes contract research services, sequencing services, and bioinformatics services. The applications segment includes drug discovery, diagnostics, and research. The end-users segment includes pharmaceutical and biotechnology companies, academic and research institutes, and hospitals and diagnostic centers.
Some of the major companies in the gene cloning market are Thermo Fisher Scientific, Agilent Technologies, Illumina, Inc., Merck KGaA, QIAGEN, Bio-Rad Laboratories, Inc., New England Biolabs, Inc., Takara Bio, Inc., and Lonza Group. Show Less   Read more